Japanese researchers authored a study in the Journal of American Ophthalmology showing reduced-fluence photodynamic monotherapy for polypoidal choroidal vasculopathy patients improved and maintained visual acuity over two years.
Ophthalmology
Carnosic acid, a chemical found in the herb rosemary, has shown promising effects on protecting retinal cells against oxidation thanks to its antioxidant and anti-inflammatory activity, according to a study published in the medical journal Investigative Ophthalmology and Visual Science.
LASIK surgery to correct compound myopic astigmatism with high cylinder was safe and effective when performed using a fast-repetition-rate excimer laser with optimized aspheric profiles and cyclotorsion control, according to a study in the Journal of Cataract and Refractive Surgery.
After the FDA approved the use of JETREA injections to treat vitreomacular adhesion last October, Los Angeles-based Retina-Vitreous Associates Medical Group claims it is the first on the West Coast to use the drug to treat VMA patients non-surgically.
Chesapeake Eye Center in Annapolis, Md., has added laser cataract surgery to its list of services with its acquisition of a LenSx femtosecond laser.
Advertisement
Further threatening his reputation, the FBI and HHS raided Florida ophthalmologist Salomon Melgen's West Palm Beach office on suspicion of Medicare fraud, part of a separate investigation unrelated to simultaneous allegations Melgen and his cousin U.S. Sen. Robert Menendez hired…
Gholam Peyman, MD, the ophthalmologist credited with inventing Lasik surgery, received an award from President Barack Obama for his contributions to American innovation.
Ophthalmology therapeutics was a $10 billion market in 2011, according to estimates in a report by investment website Seeking Alpha.
Central Utah Clinic based in Provo, Utah, has opened a new eye clinic in Mesquite, Nevada, to be operated by ophthalmologist Snow Slade, who will also practice at Mesa View Hospital, also in Mesquite.
A retinal prosthetic device for the blind and nearly blind is awaiting FDA approval for the U.S. market, according to a report by the Wall Street Journal.